Anticipated shortage of high-strength Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringe for injection

The pharmaceutical company Pfizer Australia has notified us that a new shortage of the high-strength Bicillin L-A (benzathine benzylpenicillin tetrahydrate) 1.2 million unit prefilled syringe for injection is anticipated from 20 December 2024 to 10 January 2025. 

To help, we have approved an overseas-registered product that is available from 25 November 2024 to cover any potential supply gaps. This product is also listed on the Pharmaceutical Benefits Scheme (PBS).

The ongoing shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) 600,000 unit prefilled syringes for injection is estimated to continue until April 2025. 

For detailed information, visit About the 2024-2025 shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringe for injection.

Up-to-date details about these shortages are available at the medicine shortage reports database- external site.